These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2611824

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis group.
    Sutter VL, Kwok YY.
    Antimicrob Agents Chemother; 1981 Dec; 20(6):723-5. PubMed ID: 6459765
    [Abstract] [Full Text] [Related]

  • 4. [Sensitivity of anaerobes to 8 antibiotics].
    Sedallian A.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760
    [Abstract] [Full Text] [Related]

  • 5. [Influence of the inoculum effect on minimal inhibitory concentrations of 3 derivatives of 5-nitro-imidazole and 11 other antibiotics on Bacteroides fragilis].
    Dusart G, Simeon de Buochberg M, Maillols H, Zuccarelli M, Attisso MA.
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):685-9. PubMed ID: 3054748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood.
    Gill CJ, Shungu DL, Ponticas S.
    Antimicrob Agents Chemother; 1989 Mar; 33(3):394-5. PubMed ID: 2729933
    [Abstract] [Full Text] [Related]

  • 11. Protection of Enterococcus faecalis in mixed cultures with carbapenemase-producing Escherichia coli and Bacteroide fragilis: effect of the bacterial load.
    Sevillano D, Aguilar L, Alou L, Giménez MJ, Cafini F, González N, Prieto J.
    Rev Esp Quimioter; 2013 Sep; 26(3):220-5. PubMed ID: 24080888
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ, Citron DM.
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM, Finegold SM.
    Clin Ther; 1990 Nov; 12 Suppl C():13-24. PubMed ID: 2390771
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.
    Eley A, Greenwood D.
    Antimicrob Agents Chemother; 1981 Sep; 20(3):332-5. PubMed ID: 6272629
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group. Danish study group.
    Bremmelgaard A, Jansen JE, Justesen T, Gottschau A.
    APMIS; 1994 Jun; 102(6):446-50. PubMed ID: 8068304
    [Abstract] [Full Text] [Related]

  • 20. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
    Borobio MV, Perea EJ.
    Antimicrob Agents Chemother; 1984 Mar; 25(3):342-3. PubMed ID: 6721466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.